Get the Stockscreener App
3.85
3.77%
0.14
Pre-market:
3.86
0.010
+0.26%
Lifemd Inc stock is traded at $3.85, with a volume of 1.12M.
It is up +3.77% in the last 24 hours and down -37.60% over the past month.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
See More
Previous Close:
$3.71
Open:
$3.71
24h Volume:
1.12M
Relative Volume:
0.93
Market Cap:
$185.32M
Revenue:
$193.06M
Net Income/Loss:
$-22.51M
P/E Ratio:
-6.0156
EPS:
-0.64
Net Cash Flow:
$10.63M
1W Performance:
-16.85%
1M Performance:
-37.60%
6M Performance:
-64.25%
1Y Performance:
-32.34%
1-Day Range:
$3.6201
$3.885
1-Week Range:
$3.43
$4.97
52-Week Range:
$3.43
$15.84
Lifemd Inc Stock (LFMD) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
(866) 351-5907
Address
236 FIFTH AVENUE, NEW YORK
Compare LFMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFMD
Lifemd Inc
|
3.85 | 178.58M | 193.06M | -22.51M | 10.63M | -0.64 |
|
VEEV
Veeva Systems Inc
|
244.06 | 44.34B | 3.08B | 860.33M | 1.33B | 5.1481 |
|
TEM
Tempus Ai Inc
|
70.29 | 11.69B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
101.91 | 8.68B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
50.42 | 8.74B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.74 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-18-25 | Reiterated | BTIG Research | Buy |
| Dec-10-24 | Initiated | Lake Street | Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-23-24 | Resumed | B. Riley Securities | Buy |
| Jun-05-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-30-23 | Initiated | Craig Hallum | Buy |
| Jul-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-03-23 | Initiated | H.C. Wainwright | Buy |
| Mar-10-22 | Initiated | Colliers Securities | Buy |
| Oct-04-21 | Resumed | B. Riley Securities | Buy |
View All
Lifemd Inc Stock (LFMD) Latest News
LifeMD (NASDAQ:LFMD) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
LifeMD Stock: WorkSimpli Divestment Creates Virtual Care Pure Play (NASDAQ:LFMD) - Seeking Alpha
B. Riley Comments on LifeMD's FY2025 Earnings (NASDAQ:LFMD) - MarketBeat
LifeMD Inc. (LFMD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
LifeMD (LFMD): Valuation in Focus After Earnings Miss, Guidance Cut, and Telehealth Shift - Yahoo Finance
LifeMD (NASDAQ:LFMD) Given New $9.00 Price Target at HC Wainwright - MarketBeat
KeyCorp Delivers Sobering Outlook for LifeMD, Slashing Price Target Amidst Operational Headwinds - FinancialContent
KeyCorp Issues Pessimistic Forecast for LifeMD (NASDAQ:LFMD) Stock Price - MarketBeat
LifeMD stock price target lowered to $9 at H.C. Wainwright on GLP-1 competition - Investing.com Nigeria
LifeMD (NASDAQ:LFMD) Price Target Lowered to $6.00 at Mizuho - MarketBeat
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD) and Medtronic (MDT) - The Globe and Mail
Is LifeMD Inc. stock near bottom after declineJuly 2025 PostEarnings & Weekly High Return Opportunities - newser.com
Is LifeMD Inc. stock cheap at current valuationTrade Risk Summary & Safe Entry Zone Identification - newser.com
LifeMD stock price target lowered to $8 by KeyBanc on GLP-1 competition - Investing.com South Africa
How to recover losses in LifeMD Inc. stock2025 Bull vs Bear & Daily Oversold Bounce Ideas - newser.com
Mizuho Maintains LifeMD (LFMD) Neutral Recommendation - Nasdaq
Looking at the Narrative for LifeMD as Analyst Sentiment Shifts on Recent Developments - Yahoo Finance
Custom strategy builders for tracking LifeMD Inc.Weekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com
Lake Street Capital Lowers LifeMD (NASDAQ:LFMD) Price Target to $8.00 - MarketBeat
LifeMD (NASDAQ:LFMD) Price Target Lowered to $10.00 at B. Riley - MarketBeat
LifeMD (LFMD) Receives Analyst Price Target Adjustment From HC W - GuruFocus
LifeMD (LFMD) Target Price Cut by Keybanc Analyst | LFMD Stock N - GuruFocus
Real time alert setup for LifeMD Inc. performanceJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
Mizuho Lowers Price Target for LifeMD (LFMD) to $6.00 | LFMD Sto - GuruFocus
Will LifeMD Inc. price bounce be sustainableJuly 2025 Market Mood & Breakout Confirmation Alerts - newser.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: NRX Pharmaceuticals (NRXP), LifeMD (LFMD) and Hims & Hers Health (HIMS) - The Globe and Mail
BTIG Research Issues Pessimistic Forecast for LifeMD (NASDAQ:LFMD) Stock Price - MarketBeat
LifeMD, Inc. (NASDAQ:LFMD) Q3 2025 Earnings Call Transcript - Insider Monkey
LifeMD price target lowered to $8 from $12 at KeyBanc - TipRanks
How LifeMD Inc. stock valuations compare to rivals2025 Price Targets & Entry Point Confirmation Alerts - newser.com
Is LifeMD Inc. stock positioned for long term growthJuly 2025 Closing Moves & Stepwise Entry/Exit Trade Alerts - newser.com
LifeMD Earnings Call: Growth Amid Challenges - MSN
LifeMD price target lowered to $8 from $14 at Lake Street - TipRanks
BTIG Maintains LifeMD (LFMD) Buy Recommendation - Nasdaq
Lake Street Maintains LifeMD (LFMD) Buy Recommendation - Nasdaq
LifeMD (NASDAQ:LFMD) Releases Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
LifeMD’s Big Legal Troubles Impacting Stock - StocksToTrade
LifeMD (LFMD) Sees Analyst Price Target Reduction by Lake Street - GuruFocus
LifeMD price target lowered to $10 from $12 at B. Riley - TipRanks
Why LifeMD (LFMD) Is Down 7.8% After Trimming Guidance Post-WorkSimpli Exit and Refocus - Yahoo Finance
LifeMD (LFMD): B. Riley Securities Lowers Price Target to $10.00 | LFMD Stock News - GuruFocus
LifeMD stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com Nigeria
LifeMD reports earnings miss, weak guidance amid “fierce competition” in GLP-1 market - Sherwood News
B. Riley Adjusts Price Target on LifeMD to $10 From $12, Maintains Buy Rating - MarketScreener
LifeMD price target lowered to $10 from $18 at BTIG - TipRanks
BTIG Lowers Price Target for LifeMD (LFMD) by 44.44%, Maintains Buy Rating | LFMD Stock News - GuruFocus
LifeMD stock price target lowered to $10 by BTIG amid weight loss drug competition - Investing.com Nigeria
LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates - sharewise.com
Signal strength of LifeMD Inc. stock in tech scannersJuly 2025 Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
LifeMD Inc (LFMD) Q3 2025 Earnings Call Highlights: Strong Telehealth Growth Amidst Competitive ... - Yahoo Finance
Will LifeMD’s (LFMD) Shrinking Losses Reveal a Sustainable Path to Profitability? - simplywall.st
Lifemd Inc Stock (LFMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
11.42%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):